Literature DB >> 8376327

Surface action of gentamicin on Pseudomonas aeruginosa.

J L Kadurugamuwa1, A J Clarke, T J Beveridge.   

Abstract

The mode of action of gentamicin has traditionally been considered to be at the 30S ribosomal level. However, the inhibition of bacterial protein synthesis alone appears to be insufficient to entirely explain the bactericidal effects. Bacteriolysis is also mediated through perturbation of the cell surface by gentamicin (J.L. Kadurugamuwa, J.S. Lam, and T.J. Beveridge, Antimicrob. Agents Chemother. 37:715-721, 1993). In order to separate the surface effect from protein synthesis in Pseudomonas aeruginosa PAO1, we chemically conjugated bovine serum albumin (BSA) to gentamicin, making the antibiotic too large to penetrate through the cell envelope to interact with the ribosomes of the cytoplasm. Furthermore, this BSA-gentamicin conjugate was also used to coat colloidal gold particles as a probe for electron microscopy to study the surface effect during antibiotic exposure. High-performance liquid chromatography confirmed the conjugation of the protein to the antibiotic. The conjugated gentamicin and BSA retained bactericidal activity and inhibited protein synthesis on isolated ribosomes in vitro but not on intact cells in vivo because of its exclusion from the cytoplasm. When reacted against the bacteria, numerous gentamicin-BSA-gold particles were clearly seen on the cell surfaces of whole mounts and thin sections of cells, while the cytoplasm was devoid of such particles. Disruption of the cell envelope was also observed since gentamicin-BSA and gentamicin-BSA-gold destabilized the outer membrane, evolved outer membrane blebs and vesicles, and formed holes in the cell surface. The morphological evidence suggests that the initial binding of the antibiotic disrupts the packing order of lipopolysaccharide of the outer membrane, which ultimately forms holes in the cell envelope and can lead to cell lysis. It is apparent that gentamicin has two potentially lethal effects on gram-negative cells, that resulting from inhibition of protein synthesis and that resulting from surface perturbation; the two effects in concert make aminoglycoside drugs particularly effective antibiotics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376327      PMCID: PMC206658          DOI: 10.1128/jb.175.18.5798-5805.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Gentamicin interaction with Pseudomonas aeruginosa cell envelope.

Authors:  N L Martin; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

2.  Ultrastructural localization of intracellular antigens by the use of protein A-gold complex.

Authors:  J Roth; M Bendayan; L Orci
Journal:  J Histochem Cytochem       Date:  1978-12       Impact factor: 2.479

3.  Radioimmunoassay of an antibiotic: gentamicin.

Authors:  J E Lewis; J C Nelson; H A Elder
Journal:  Nat New Biol       Date:  1972-10-18

4.  Site specificity of metallic ion binding in Escherichia coli K-12 lipopolysaccharide.

Authors:  F G Ferris; T J Beveridge
Journal:  Can J Microbiol       Date:  1986-01       Impact factor: 2.419

Review 5.  Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

6.  Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations.

Authors:  C Josepovitz; E Pastoriza-Munoz; D Timmerman; M Scott; S Feldman; G J Kaloyanides
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

7.  Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027.

Authors:  S G Walker; T J Beveridge
Journal:  Can J Microbiol       Date:  1988-01       Impact factor: 2.419

8.  Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa.

Authors:  B Loh; C Grant; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

10.  Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

View more
  71 in total

1.  Stages of polymyxin B interaction with the Escherichia coli cell envelope.

Authors:  R Daugelavicius; E Bakiene; D H Bamford
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Membrane vesicles: an overlooked component of the matrices of biofilms.

Authors:  Sarah R Schooling; Terry J Beveridge
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

3.  Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c.

Authors:  E C Spindler; J D F Hale; T H Giddings; R E W Hancock; R T Gill
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Characterization of gentamicin 2'-N-acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan.

Authors:  K G Payie; A J Clarke
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

5.  Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability.

Authors:  John-Jairo Aguilera-Correa; Antonio L Doadrio; Ana Conde; Maria-Angeles Arenas; Juan-Jose de-Damborenea; María Vallet-Regí; Jaime Esteban
Journal:  J Mater Sci Mater Med       Date:  2018-07-20       Impact factor: 3.896

6.  Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.

Authors:  Vanessa E Rees; Jürgen B Bulitta; Antonio Oliver; Brian T Tsuji; Craig R Rayner; Roger L Nation; Cornelia B Landersdorfer
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

7.  Reducing Staphylococcus aureus biofilm formation on stainless steel 316L using functionalized self-assembled monolayers.

Authors:  Kristen M Kruszewski; Laura Nistico; Mark J Longwell; Matthew J Hynes; Joshua A Maurer; Luanne Hall-Stoodley; Ellen S Gawalt
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-01-18       Impact factor: 7.328

8.  Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047.

Authors:  C R Rayner; L L Ioannides-Demos; J A Brien; L L Liolios; W J Spicer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Influence of O polysaccharides on biofilm development and outer membrane vesicle biogenesis in Pseudomonas aeruginosa PAO1.

Authors:  Kathleen Murphy; Amber J Park; Youai Hao; Dyanne Brewer; Joseph S Lam; Cezar M Khursigara
Journal:  J Bacteriol       Date:  2014-01-24       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.